OTC stock swing trader
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Be careful, new buyers
I made mistake at BCNN After PPS pull back I bought in, but profits taking sell continue, now I am a bag holder.
Charts scared me to get in Yesterday, Looks like Tomorrow profits taking sell will be coming< Not time to get in at this level. Chase high is a risk play, waiting for pull back.
Can you reach the emergence LLC company and ask them what' going on? if they say they are going to do R/S again, then ETEK will move up.
Need buy volume to break out 0.001 Tomorrow.
LOOKS GOOD MK IS VERY BUSY, BUY AND HOLD ON IS A ONLY RIGHT CHOICE..
Very few to see a stock moving fast like STAL in the two years.
Looks like some people's profits taking sell continue today.
suddently ask buyers coming in, 0.0008 will gone any moment. Ready to run.
We are going to break out 0.003 with this good revenue news today.
Looks like RDGL is ready to run, See Tomorrow how the markets will be doing? Green dayt
Bought in at 0.0008 today, ready to run
See Tomorrow rebound.
No reasons to gap down 36% PPS, MMs are playing wrong games. MC only $700,000, much lower than revenue.
No reasons to gap down 36% PPS, MMs are playing wrong games. MC only $700,000, much lower than revenue.
$1.3mm is the whole year's revenue in 2023? right?
RDGL is a very undervalued stock, time to move up., let 's break out 0.10 first in this month.
The company currently has no operations and is negotiating merger terms with a couple different candidates.
DPLS dilution continue, PPS down, I was out to cut small lose. Waiting for entry point.
If 4 come out ,i will take it out again.
Added one mm shares at 0.0004, see 0.0008 soon
need merge news lieked
BCNN is ready to rebound, I was in at 0.0035 today. See Tomorrow run.
I believe that profits taking sell push the PPS down. I am waiting for down more to get in..
LOOKS LIKE ITS READY TO BIG REBOUND, cLOSE ON 0.0015 FOR NEXT DAY RUN?
Bought some at 0.0008 today, looks like ask 0.0008 hide some shares for sale.
See great green week
Following you, just bought 1mm shares at 0.0011. hope to make some profits soon.
0.007 soon, 0.07 good future, 0.0007 never see it.
Red Friday: 29 bid sellers , 27 ask buyers,15 MMs traders. Looks like some people need cash for holiday season, some people for tax cut sell.. Good chance for long to add more shares for making big profits within 5 months, meaning soon.
MMs are playing game to sell or buy 1 shares to control PPS.
Big market red, RDGL too. Business continue to go ahead, another buy opportunity
According to following update, All tests will be finished at 4th Quarter of this year. First Quarter of next year will be submit IDE and get FDA approval, then begin to conduct clinical Trials in human By MAYO Clinic. So I predict PPS will be reached 0.50 by end of year. , After IDE Submit and FDA approval, PPS will be hitted $1 at least. Let's see..
Submittal of the IDE - (Q211938/S001)
Our next IDE application will be an amendment to the previous submittal. We are systematically preparing the answers to the 60 previous FDA comments. And as we near completion we felt it was worth the investment to redo a few studies to ensure that the FDA comments are fully addressed. This includes the polymer and hydrogel shelf-lives, the effect of radiation on the hydrogel, and the effect of polymer freeze-thaw cycles on the hydrogel properties. These tests will be completed next quarter. Important content is the VX2 Tumor Animal Study report and executing the Genotox protocol.
VX-2/Rabbit Animal Study - Dr. Rebecca Krimins has treated 12 rabbits. Next quarter she will treat the last nine rabbits, submit the data to Pearl Pathways for independent review, and write the report.
Genotoxicity – Based on the FDA recommendation; on September 29th we participated in the Pre-Sub meeting to discuss the Genotoxicty Chemical Characterization Protocol (GCCP). We now feel sufficiently confident to initiate the genotox testing next month.
Mayo Clinic Protocol and Institutional Review Board (IRB)
After receiving FDA approval to conduct clinical trials we need formal approval from the Mayo Clinic IRB. In anticipation of this step and to help expedite the proccess we have submitted the Clinical Trial Protocol to their “gatekeeper” for comments. We have also been conducting certification training for Dr. Paz Fumagalli. Next quarter we are planning to complete the final training certification step using high activity RadioGel™ in a full-dress rehearsal operating theater.
RDGL will be hitted $1 within 5 months, one month closer to IDE Submit and FDA Approval.
I really hope:Trager53, Your 0.07 target will be hitted this year. DPLS chart shows bear market is finished, uptrend and bull market will be coming. See next green week.
See next week run.
WOW good green Friday for next week run.. We are closer to the day for gap up.
Question for you: BETS why offering price is 0.36 and 0.46 but markets price gap down and sold down to 0.045 area now, looks unreasonable. Thanks in advance.
Bit Brother Limited Announces Pricing of $5.04 Million Registered Direct Offering
CHANGSHA, China, Oct. 26, 2023 /PRNewswire/ -- Bit Brother Limited ("Bit Brother, " "We" or the "Company") (NASDAQ: BETS), announced today that it has entered into a securities purchase agreement with certain accredited investors to sell $5.04 million of its Class A ordinary shares, Class B warrants and Class C warrants in a registered direct offering.
Under the terms of the securities purchase agreement, Bit Brother has agreed to sell 14,000,000 Class A ordinary shares, Class B warrants to purchase 14,000,000 Class A ordinary shares, and Class C warrants to purchase 14,000,000 Class A ordinary shares at a combined purchase price of $0.36 per Class A ordinary share and associated warrants. The Class B warrants will be exercisable immediately upon the date of issuance for a term of five years and have an initial exercise price of $0.36 and the Class C warrants will be exercisable immediately upon the date of issuance for a term of two years and have an initial exercise price of $0.46 subject to certain reset 30 trading days after closing. In addition to the customary cashless exercise rights provided in both the Class B warrants and the Class C warrants, the Class C warrants will also provide an alternate cashless exercise allowing the holder to right to exercise at any time, on a cashless exercise basis for a larger number of Class A ordinary shares under certain conditions.
The gross proceeds to Bit Brother are estimated to be $5.04 million before deducting the placement agent fees and other estimated offering expenses. The registered direct offering is expected to close on or about October 30, 2023, subject to the satisfaction of customary closing conditions.
Maxim Group LLC acted as sole placement agent for the offering.
The Class A ordinary shares, Class B warrants and Class C warrants being sold pursuant to the registered direct offering is being made pursuant to a shelf registration statement on Form F-3 (File No. 333-256628), previously filed with the Securities and Exchange Commission (the "SEC") on May 28, 2021, amended on June 3, 2021 and declared effective on June 8, 2021. Such securities are being offered only by means of a prospectus. A prospectus supplement and the accompanying prospectus relating to and describing the terms of the registered direct offering will be filed with the SEC. When available, copies of the prospectus supplement and the accompanying prospectus relating to the registered direct offering may be obtained at the SEC's website www.sec.gov or by contacting Maxim Group LLC, 300 Park Avenue, 16th Floor, New York, NY 10022, at 212-895-3745.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.
About Bit Brother Limited
Bit Brother Ltd is a multifaceted corporation with operations spanning business management in China and blockchain and cryptocurrency ventures in the United States. Within the U.S. jurisdiction, the company strategically manages and integrates cryptocurrency mining facilities. With a dedicated team of specialists, company has successfully expanded two mining ventures and is committed to further growth. For more information, please visit: www.bitbrother.com.
Forward-Looking Statements Disclaimer
This press release contains certain statements that may include "forward-looking statements." All statements other than statements of historical fact included herein are "forward-looking statements." These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions, involving known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including the risk factors discussed in the Company's periodic reports that are filed with the Securities and Exchange Commission and available on the SEC's website (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these risk factors. Other than as required under the applicable securities laws, the Company does not assume a duty to update these forward-looking statements.
https://c212.net/c/img/favicon.png?sn=CN50007&sd=2023-10-26 View original content:https://www.prnewswire.com/news-releases/bit-brother-limited-announces-pricing-of-5-04-million-registered-direct-offering-3019
Now market price is 0.0445, much lower than offering price at 0.25. what's happened for them and for market?